SKI Market

A+| A| A-|

Indian Indices

Sensex

77,664.00 0.00
( 0.00%)

Global Indices

Nasdaq

49,330.80 -180.24
(-0.36%)

Dow Jones

7,129.46 -29.44
(-0.41%)

Hang Seng

59,249.10 -336.76
(-0.57%)

Nikkei 225

10,468.22 -8.24
(-0.08%)

Forex

USD-INR

93.75 0.31
(0.34%)

EUR-INR

109.98 0.10
(0.09%)

GBP-INR

126.66 0.42
(0.33%)

JPY-INR

0.59 0.00
(0.23%)

YOU ARE HERE :
HOME
Markets
Equity
Company News

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

377.5510998

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

23.98

111263.95

EPS(TTM)

Face Value()

Div & Yield %

55.59

0.6

Date	Headline
23-Apr-2026	Shree Ganesh Remedies Ltd Spikes 3.78%
06-Mar-2026	Dr Reddy's Lab gets EIR from USFDA for Srikakulam facility
19-Feb-2026	Dr. Reddy’s Labs acquires 'Progynova' portfolio from UK's Mercury Pharma Group
19-Feb-2026	Nifty drops below 25,650 mark; auto shares snap 2-day gains
22-Jan-2026	Dr Reddy’s Lab Q3 PAT drops 14% YoY to Rs 1,210 cr
21-Jan-2026	Dr Reddy's Laboratories consolidated net profit declines 14.42% in the December 2025 quarter
01-Jan-2026	Dr Reddy’s Swiss subsidiary gets USFDA CRL for biosimilar AVT03
24-Dec-2025	Dr Reddys Laboratories to announce Quarterly Result
09-Dec-2025	Dr Reddys Laboratories allots 9,165 equity shares under ESOS
08-Dec-2025	Dr Reddy’s Lab arm inks pact with Immutep SAS for novel cancer immunotherapy

<< < 1 2 3 > >>

77,664.00 0.00 ( 0.00%)

49,330.80 -180.24 (-0.36%)

7,129.46 -29.44 (-0.41%)

59,249.10 -336.76 (-0.57%)

10,468.22 -8.24 (-0.08%)

93.75 0.31 (0.34%)

109.98 0.10 (0.09%)

126.66 0.42 (0.33%)

0.59 0.00 (0.23%)